BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33723329)

  • 1. Metabolic activity of extranodal NK/T cell lymphoma on
    Lim CH; Yoon SE; Kim SJ; Cho J; Ko YH; Lee KH; Kim WS
    Sci Rep; 2021 Mar; 11(1):5879. PubMed ID: 33723329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
    Wu LL; Liang JH; Wang L; Xu W; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
    Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
    Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic evaluation of the prognostic value of
    Xu P; Guo R; You J; Cheng S; Li J; Zhong H; Sun C; Xu H; Huang H; Li B; Zhao W
    Ann Hematol; 2021 Apr; 100(4):1039-1047. PubMed ID: 33634350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type.
    Jiang C; Zhang X; Jiang M; Zou L; Su M; Kosik RO; Tian R
    Ann Nucl Med; 2015 Jun; 29(5):442-51. PubMed ID: 25801633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomograms based on SUVmax of
    Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
    Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pretreatment evaluation of
    Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
    Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].
    Zhang Y; Zhou J; Wang L; Li JY; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):885-890. PubMed ID: 33113633
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic value of baseline, interim and end-of-treatment 18F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis.
    Wang H; Shen G; Jiang C; Li L; Cui F; Tian R
    PLoS One; 2018; 13(3):e0194435. PubMed ID: 29558489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate timing to perform an interim
    Wang R; Zhang Y; Fan Q; Jiang M; Zou L; Su M
    Ann Hematol; 2024 Mar; 103(3):885-892. PubMed ID: 38030892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck.
    Suh C; Kang YK; Roh JL; Kim MR; Kim JS; Huh J; Lee JH; Jang YJ; Lee BJ
    J Nucl Med; 2008 Nov; 49(11):1783-9. PubMed ID: 18927319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extranodal NK/T-cell lymphoma with localized relapse in bone marrow of lower leg detected using PET-CT.
    Nakamura T; Tatetsu H; Higuchi Y; Endo S; Shiraishi S; Kawanaka K; Imakane D; Sonoda M; Furuta R; Shichijo T; Honda Y; Karube K; Mikami Y; Nosaka K; Matsuoka M; Yasunaga JI
    J Clin Exp Hematop; 2024; 64(1):45-51. PubMed ID: 38538318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of 18F-FDG PET/CT for cutaneous extranodal natural killer/T-cell lymphoma, nasal type.
    Liu C; Zhang Y; Zhang Y; Wang M; Liu R; Liu X; Hu S
    Nucl Med Commun; 2016 May; 37(5):446-52. PubMed ID: 26657218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT for Prognostic Stratification of Patients With Extranodal Natural Killer/T-Cell Lymphoma.
    Qin C; Yang S; Sun X; Xia X; Li C; Lan X
    Clin Nucl Med; 2019 Mar; 44(3):201-208. PubMed ID: 30624268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma.
    Kim CY; Hong CM; Kim DH; Son SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1321-9. PubMed ID: 23674211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal-Type NK/T-Cell Lymphoma Involvement of the Vocal Cord on FDG PET/CT.
    Huang M; Wang R; Shen G; Tian R
    Clin Nucl Med; 2022 Oct; 47(10):914-915. PubMed ID: 35619195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weakly supervised deep learning for determining the prognostic value of
    Guo R; Hu X; Song H; Xu P; Xu H; Rominger A; Lin X; Menze B; Li B; Shi K
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3151-3161. PubMed ID: 33611614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Application Value of True Whole-body PET/CT Scanning Protocol in Patients of Extranodal NK/T Cell Lymphoma].
    Li FL; Su MG; Shi DZ; Liang FL; Li L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):245-251. PubMed ID: 32220195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic Value of Interim
    Wang TS; Qiao WL; Xing Y; Zhao JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):731-734. PubMed ID: 34105465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.